These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2761918)

  • 1. Prenatal screening for human immunodeficiency virus infection: purpose, priorities, protocol, and pitfalls.
    Duff P
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):403-4. PubMed ID: 2761918
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired immunodeficiency syndrome: suggested protocol for counseling and screening in pregnancy.
    Sachs BP; Tuomala R; Frigoletto F
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):408-11. PubMed ID: 3627591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
    Spencer K; Bindra R; Cacho AM; Nicolaides KH
    Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical issues in caring for pregnant women and newborns at risk for human immunodeficiency virus infection.
    Nolan K
    Semin Perinatol; 1989 Feb; 13(1):55-65. PubMed ID: 2919291
    [No Abstract]   [Full Text] [Related]  

  • 5. Principles of screening.
    Evans MI; Galen RS; Britt DW
    Semin Perinatol; 2005 Dec; 29(6):364-6. PubMed ID: 16533648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAP issues statement on perinatal HIV infection.
    Am Fam Physician; 1989 Mar; 39(3):390, 393. PubMed ID: 2923036
    [No Abstract]   [Full Text] [Related]  

  • 7. Human immunodeficiency virus infection/AIDS in children: the next decade.
    Ammann AJ
    Pediatrics; 1994 Jun; 93(6 Pt 1):930-5. PubMed ID: 8190579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mass screening among low risk groups in the fight against AIDS].
    Tynes T; Skogstad M; Kristensen P
    Tidsskr Nor Laegeforen; 1987 Nov; 107(31):2767-9. PubMed ID: 3424317
    [No Abstract]   [Full Text] [Related]  

  • 9. Second-trimester maternal serum screening for Down syndrome in Mainland China.
    Liao C; Huang Y; Li D; Song S; Yi C; Zhou J
    Prenat Diagn; 2006 Dec; 26(13):1271-2. PubMed ID: 17139699
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
    Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC
    Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA; Ying J; Beazoglou T; Egan JF
    Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
    Muller PR; Cocciolone R; Haan EA; Wilkinson C; Scott H; Sage L; Bird R; Hutchinson R; Chan A
    Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program.
    Krantz DA; Hallahan TW; Macri VJ; Macri JN
    Prenat Diagn; 2005 Aug; 25(8):635-40. PubMed ID: 16049986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxoplasmosis in pregnancy: prevention, prenatal diagnosis and treatment].
    Hohlfeld P; Biedermann K; Extermann P; Gyr T
    Schweiz Med Wochenschr Suppl; 1995; 65():62S-69S. PubMed ID: 7716455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in antenatal screening for Down syndrome.
    Wald NJ; Hackshaw AK
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Aug; 14(4):563-80. PubMed ID: 10985931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal screening for Down syndrome: the problem of recurrent false-positives.
    Wald NJ; Huttly WJ; Rudnicka AR
    Prenat Diagn; 2004 May; 24(5):389-92. PubMed ID: 15164416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal biochemical serum screening for Down syndrome in pregnancy with human immunodeficiency virus infection.
    Le Meaux JP; Tsatsaris V; Schmitz T; Fulla Y; Launay O; Goffinet F; Azria E
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):223-30. PubMed ID: 18669715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anomalous marker patterns in Down syndrome screening.
    Wald NJ; Bestwick JP; Barnes IM; Kellner LH
    Prenat Diagn; 2007 Feb; 27(2):185-6. PubMed ID: 17266168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.